
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $6.5B | $6.3B | $6.2B | $6.3B | $6.4B | |
Revenue Growth (YoY) | -16.01% | -3.49% | -2.06% | 1.44% | 2.24% | |
Cost of Revenues | $2.1B | $2.4B | $2.3B | $2.5B | $2.7B | |
Gross Profit | $4.4B | $3.9B | $3.9B | $3.7B | $3.7B | |
Gross Profit Margin | 67.56% | 62.22% | 62.84% | 59.84% | 58.02% | |
R&D Expenses | $210M | $339M | $471M | $528M | $469M | |
Selling, General & Admin | $1.4B | $1.7B | $1.7B | $1.9B | $1.8B | |
Other Inc / (Exp) | -$95M | -$128M | -$161M | -$127M | -$159M | |
Operating Expenses | $1.6B | $2B | $2.2B | $2.4B | $2.2B | |
Operating Income | $2.8B | $1.9B | $1.7B | $1.3B | $1.5B | |
Net Interest Expenses | -- | $258M | $422M | $527M | $520M | |
EBT. Incl. Unusual Items | $2.8B | $1.5B | $1.1B | $673M | $807M | |
Earnings of Discontinued Ops. | -$96M | -- | -- | -- | -- | |
Income Tax Expense | $496M | $178M | $205M | -$350M | -$57M | |
Net Income to Company | $2.3B | $1.4B | $917M | $1B | $864M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $2.2B | $1.4B | $917M | $1B | $864M | |
Basic EPS (Cont. Ops) | $8.53 | $5.33 | $3.61 | $4.01 | $3.36 | |
Diluted EPS (Cont. Ops) | $8.53 | $5.31 | $3.59 | $3.99 | $3.33 | |
Weighted Average Basic Share | $253.1M | $253.5M | $254.1M | $255.2M | $257M | |
Weighted Average Diluted Share | $253.1M | $254.2M | $255.2M | $256.3M | $259.2M | |
EBITDA | $2.9B | $2B | $1.8B | $1.4B | $1.6B | |
EBIT | $2.8B | $1.8B | $1.5B | $1.2B | $1.3B | |
Revenue (Reported) | $6.5B | $6.3B | $6.2B | $6.3B | $6.4B | |
Operating Income (Reported) | $2.8B | $1.9B | $1.7B | $1.3B | $1.5B | |
Operating Income (Adjusted) | $2.8B | $1.8B | $1.5B | $1.2B | $1.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.5B | $1.6B | $1.5B | $1.6B | $1.5B | |
Revenue Growth (YoY) | -15.39% | 4.05% | -1.85% | 5.46% | -6.72% | |
Cost of Revenues | $591M | $561M | $580M | $665M | $672M | |
Gross Profit | $915M | $1B | $958M | $957M | $841M | |
Gross Profit Margin | 60.76% | 64.2% | 62.29% | 59% | 55.59% | |
R&D Expenses | $67M | $96M | $129M | $112M | $96M | |
Selling, General & Admin | $382M | $371M | $435M | $431M | $420M | |
Other Inc / (Exp) | $1M | $4M | -$27M | -$47M | -$100M | |
Operating Expenses | $449M | $467M | $564M | $543M | $516M | |
Operating Income | $466M | $539M | $394M | $414M | $325M | |
Net Interest Expenses | -- | $97M | $132M | $131M | $124M | |
EBT. Incl. Unusual Items | $467M | $442M | $235M | $236M | $101M | |
Earnings of Discontinued Ops. | $4M | -- | -- | -- | -- | |
Income Tax Expense | $72M | $94M | $58M | $35M | $14M | |
Net Income to Company | $395M | $348M | $177M | $201M | $87M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $399M | $348M | $177M | $201M | $87M | |
Basic EPS (Cont. Ops) | $1.58 | $1.37 | $0.70 | $0.78 | $0.34 | |
Diluted EPS (Cont. Ops) | $1.58 | $1.36 | $0.69 | $0.78 | $0.33 | |
Weighted Average Basic Share | $253.1M | $253.6M | $254.4M | $255.7M | $257.9M | |
Weighted Average Diluted Share | $253.1M | $255.1M | $256.2M | $258.4M | $261M | |
EBITDA | $505M | $592M | $424M | $432M | $309M | |
EBIT | $467M | $539M | $367M | $367M | $225M | |
Revenue (Reported) | $1.5B | $1.6B | $1.5B | $1.6B | $1.5B | |
Operating Income (Reported) | $466M | $539M | $394M | $414M | $325M | |
Operating Income (Adjusted) | $467M | $539M | $367M | $367M | $225M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $6.3B | $6.4B | $6.1B | $6.3B | $6.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.2B | $2.4B | $2.3B | $2.6B | $2.7B | |
Gross Profit | $4.1B | $4B | $3.8B | $3.7B | $3.6B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $232M | $368M | $504M | $511M | $453M | |
Selling, General & Admin | $1.4B | $1.7B | $1.8B | $1.9B | $1.7B | |
Other Inc / (Exp) | -$58M | -$125M | -$188M | -$147M | -$212M | |
Operating Expenses | $1.7B | $2B | $2.3B | $2.4B | $2.2B | |
Operating Income | $2.4B | $2B | $1.6B | $1.3B | $1.4B | |
Net Interest Expenses | -- | $355M | $457M | $526M | $513M | |
EBT. Incl. Unusual Items | $2.4B | $1.5B | $915M | $674M | $672M | |
Earnings of Discontinued Ops. | -$61M | -$4M | -- | -- | -- | |
Income Tax Expense | $458M | $200M | $169M | -$373M | -$78M | |
Net Income to Company | $1.9B | $1.3B | $746M | $1B | $750M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $1.9B | $1.3B | $746M | $1B | $750M | |
Basic EPS (Cont. Ops) | $7.33 | $5.12 | $2.93 | $4.10 | $2.91 | |
Diluted EPS (Cont. Ops) | $7.33 | $5.10 | $2.92 | $4.09 | $2.88 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $2.5B | $2.1B | $1.6B | $1.4B | $1.5B | |
EBIT | $2.4B | $1.9B | $1.4B | $1.2B | $1.2B | |
Revenue (Reported) | $6.3B | $6.4B | $6.1B | $6.3B | $6.3B | |
Operating Income (Reported) | $2.4B | $2B | $1.6B | $1.3B | $1.4B | |
Operating Income (Adjusted) | $2.4B | $1.9B | $1.4B | $1.2B | $1.2B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.5B | $1.6B | $1.5B | $1.6B | $1.5B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $591M | $561M | $580M | $665M | $672M | |
Gross Profit | $915M | $1B | $958M | $957M | $841M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $67M | $96M | $129M | $112M | $96M | |
Selling, General & Admin | $382M | $371M | $435M | $431M | $420M | |
Other Inc / (Exp) | $1M | $4M | -$27M | -$47M | -$100M | |
Operating Expenses | $449M | $467M | $564M | $543M | $516M | |
Operating Income | $466M | $539M | $394M | $414M | $325M | |
Net Interest Expenses | -- | $97M | $132M | $131M | $124M | |
EBT. Incl. Unusual Items | $467M | $442M | $235M | $236M | $101M | |
Earnings of Discontinued Ops. | $4M | -- | -- | -- | -- | |
Income Tax Expense | $72M | $94M | $58M | $35M | $14M | |
Net Income to Company | $395M | $348M | $177M | $201M | $87M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $399M | $348M | $177M | $201M | $87M | |
Basic EPS (Cont. Ops) | $1.58 | $1.37 | $0.70 | $0.78 | $0.34 | |
Diluted EPS (Cont. Ops) | $1.58 | $1.36 | $0.69 | $0.78 | $0.33 | |
Weighted Average Basic Share | $253.1M | $253.6M | $254.4M | $255.7M | $257.9M | |
Weighted Average Diluted Share | $253.1M | $255.1M | $256.2M | $258.4M | $261M | |
EBITDA | $505M | $592M | $424M | $432M | $309M | |
EBIT | $467M | $539M | $367M | $367M | $225M | |
Revenue (Reported) | $1.5B | $1.6B | $1.5B | $1.6B | $1.5B | |
Operating Income (Reported) | $466M | $539M | $394M | $414M | $325M | |
Operating Income (Adjusted) | $467M | $539M | $367M | $367M | $225M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $12M | $737M | $706M | $693M | $675M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1B | $1.4B | $1.5B | $1.7B | $1.4B | |
Inventory | $913M | $915M | $1B | $1.3B | $1.3B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $930M | $726M | $747M | $756M | $994M | |
Total Current Assets | $3.6B | $3.8B | $3.9B | $4.5B | $4.3B | |
Property Plant And Equipment | $984M | $973M | $1B | $1.2B | $1.2B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $4.6B | $4.6B | $4.6B | $4.6B | $4.7B | |
Other Intangibles | $503M | $651M | $649M | $533M | $1.4B | |
Other Long-Term Assets | $452M | $694M | $754M | $1.2B | $1.5B | |
Total Assets | $10.1B | $10.7B | $11B | $12.1B | $13.1B | |
Accounts Payable | $259M | $1.4B | $1.1B | $1.3B | $1.2B | |
Accrued Expenses | $659M | $1B | $1.2B | $1.4B | $1.4B | |
Current Portion Of Long-Term Debt | $1.3B | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $128M | -- | -- | -- | -- | |
Total Current Liabilities | $2.7B | $2.6B | $2.5B | $2.9B | $2.7B | |
Long-Term Debt | -- | $9.1B | $8.9B | $8.8B | $8.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.6B | $12.2B | $11.8B | $12.1B | $12.6B | |
Common Stock | -- | $3M | $3M | $3M | $3M | |
Other Common Equity Adj | -$622M | -$513M | -$564M | -$541M | -$649M | |
Common Equity | $5.5B | -$1.5B | -$892M | -$70M | $472M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $5.5B | -$1.5B | -$892M | -$70M | $472M | |
Total Liabilities and Equity | $10.1B | $10.7B | $11B | $12.1B | $13.1B | |
Cash and Short Terms | $12M | $737M | $706M | $693M | $675M | |
Total Debt | $1.3B | $9.1B | $8.9B | $8.8B | $8.9B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $141M | $694M | $459M | $575M | $547M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1B | $1.3B | $1.4B | $1.5B | $1.5B | |
Inventory | $924M | $946M | $1.1B | $1.3B | $1.4B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $782M | $757M | $755M | $811M | $1B | |
Total Current Assets | $3B | $3.7B | $3.8B | $4.2B | $4.4B | |
Property Plant And Equipment | $986M | $970M | $1.1B | $1.2B | $1.2B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $4.6B | $4.6B | $4.6B | $4.6B | $4.7B | |
Other Intangibles | $482M | $665M | $621M | $718M | $1.4B | |
Other Long-Term Assets | $594M | $640M | $704M | $1.2B | $1.5B | |
Total Assets | $9.6B | $10.6B | $10.8B | $11.9B | $13.2B | |
Accounts Payable | $264M | $1.1B | $996M | $955M | $1B | |
Accrued Expenses | $759M | $1B | $1.2B | $1.4B | $1.4B | |
Current Portion Of Long-Term Debt | $1.5B | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $44M | -- | -- | -- | -- | |
Total Current Liabilities | $2.9B | $2.3B | $2.3B | $2.5B | $2.6B | |
Long-Term Debt | -- | $9.1B | $8.7B | $8.7B | $8.9B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.9B | $11.8B | $11.5B | $11.8B | $12.6B | |
Common Stock | -- | $3M | $3M | $3M | $3M | |
Other Common Equity Adj | -$689M | -$529M | -$534M | -$577M | -$617M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $4.7B | -$1.3B | -$737M | $48M | $542M | |
Total Liabilities and Equity | $9.6B | $10.6B | $10.8B | $11.9B | $13.2B | |
Cash and Short Terms | $141M | $694M | $459M | $575M | $547M | |
Total Debt | $1.5B | $9.1B | $8.7B | $8.7B | $9B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.3B | $1.4B | $917M | $1B | $864M | |
Depreciation & Amoritzation | $142M | $195M | $212M | $236M | $277M | |
Stock-Based Compensation | $40M | $59M | $75M | $101M | $105M | |
Change in Accounts Receivable | $13M | -$277M | -$123M | -$212M | $383M | |
Change in Inventories | $34M | -$138M | -$220M | -$230M | -$131M | |
Cash From Operations | $2.2B | $2.5B | $858M | $799M | $939M | |
Capital Expenditures | $255M | $488M | $427M | $261M | $351M | |
Cash Acquisitions | -- | -- | -- | -- | -$166M | |
Cash From Investing | -$258M | -$837M | -$420M | -$260M | -$513M | |
Dividends Paid (Ex Special Dividend) | -- | -$145M | -$290M | -$294M | -$297M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.5B | $9.5B | -- | $80M | $1.2B | |
Long-Term Debt Repaid | -- | -$1.6B | -$108M | -$338M | -$1.2B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$3.5B | -$8.7B | -$35M | -$17M | -$60M | |
Cash From Financing | -$2.2B | -$977M | -$433M | -$569M | -$368M | |
Beginning Cash (CF) | $319M | $70M | $737M | $706M | $693M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$246M | $644M | $5M | -$30M | $58M | |
Ending Cash (CF) | $12M | $737M | $706M | $693M | $675M | |
Levered Free Cash Flow | $1.9B | $2B | $431M | $538M | $588M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $395M | $348M | $177M | $201M | $87M | |
Depreciation & Amoritzation | $38M | $53M | $57M | $65M | $84M | |
Stock-Based Compensation | $11M | $15M | $22M | $26M | $24M | |
Change in Accounts Receivable | -$40M | $54M | $39M | $163M | -$85M | |
Change in Inventories | -$33M | $14M | -$38M | $19M | $3M | |
Cash From Operations | $1.5B | $123M | $114M | $76M | $75M | |
Capital Expenditures | $38M | $63M | $54M | $96M | $97M | |
Cash Acquisitions | -- | -- | -- | -- | -$75M | |
Cash From Investing | -$38M | -$63M | -$54M | -$96M | -$172M | |
Dividends Paid (Ex Special Dividend) | -- | -$71M | -$73M | -$70M | -$71M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $90M | |
Long-Term Debt Repaid | -$566M | -$2M | -$252M | -$2M | -$93M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$551M | -$18M | -$1M | -$2M | -$1M | |
Cash From Financing | -$1.4B | -$91M | -$326M | -$74M | -$75M | |
Beginning Cash (CF) | $70M | $737M | $706M | $693M | $675M | |
Foreign Exchange Rate Adjustment | -$14M | -$12M | $19M | -$24M | $44M | |
Additions / Reductions | $105M | -$31M | -$266M | -$94M | -$172M | |
Ending Cash (CF) | $141M | $694M | $459M | $575M | $547M | |
Levered Free Cash Flow | $1.5B | $60M | $60M | -$20M | -$22M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.9B | $1.3B | $746M | $1B | $750M | |
Depreciation & Amoritzation | $147M | $210M | $216M | $244M | $296M | |
Stock-Based Compensation | $41M | $63M | $82M | $105M | $103M | |
Change in Accounts Receivable | $129M | -$183M | -$138M | -$88M | $135M | |
Change in Inventories | $11M | -$91M | -$272M | -$173M | -$147M | |
Cash From Operations | $3B | $1.1B | $849M | $761M | $938M | |
Capital Expenditures | $253M | $513M | $418M | $303M | $352M | |
Cash Acquisitions | -- | -- | -- | -- | -$241M | |
Cash From Investing | -$247M | -$862M | -$411M | -$302M | -$589M | |
Dividends Paid (Ex Special Dividend) | -- | -$216M | -$292M | -$291M | -$298M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $80M | $1.3B | |
Long-Term Debt Repaid | -$566M | -$1.1B | -$358M | -$88M | -$1.3B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$3.4B | -$8.1B | -$18M | -$18M | -$59M | |
Cash From Financing | -$2.9B | $293M | -$668M | -$317M | -$369M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$140M | $508M | -$230M | $142M | -$20M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $2.8B | $564M | $431M | $458M | $586M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $395M | $348M | $177M | $201M | $87M | |
Depreciation & Amoritzation | $38M | $53M | $57M | $65M | $84M | |
Stock-Based Compensation | $11M | $15M | $22M | $26M | $24M | |
Change in Accounts Receivable | -$40M | $54M | $39M | $163M | -$85M | |
Change in Inventories | -$33M | $14M | -$38M | $19M | $3M | |
Cash From Operations | $1.5B | $123M | $114M | $76M | $75M | |
Capital Expenditures | $38M | $63M | $54M | $96M | $97M | |
Cash Acquisitions | -- | -- | -- | -- | -$75M | |
Cash From Investing | -$38M | -$63M | -$54M | -$96M | -$172M | |
Dividends Paid (Ex Special Dividend) | -- | -$71M | -$73M | -$70M | -$71M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $90M | |
Long-Term Debt Repaid | -$566M | -$2M | -$252M | -$2M | -$93M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$551M | -$18M | -$1M | -$2M | -$1M | |
Cash From Financing | -$1.4B | -$91M | -$326M | -$74M | -$75M | |
Beginning Cash (CF) | $70M | $737M | $706M | $693M | $675M | |
Foreign Exchange Rate Adjustment | -$14M | -$12M | $19M | -$24M | $44M | |
Additions / Reductions | $105M | -$31M | -$266M | -$94M | -$172M | |
Ending Cash (CF) | $141M | $694M | $459M | $575M | $547M | |
Levered Free Cash Flow | $1.5B | $60M | $60M | -$20M | -$22M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.